Iron cycle disruption by heme oxygenase-1 activation leads to a reduced breast cancer cell survival

Area of Science:

• Biochemistry
• Oncology
• Cell Biology

Background:

• Heme oxygenase-1 (HO-1) regulates processes in breast cancer.
• Deregulation of iron metabolism is linked to tumor progression.
• The interplay between HO-1 and iron proteins in breast cancer is not fully understood.

Purpose of the Study:

• To investigate the regulatory relationship between HO-1 and iron proteins in breast cancer.
• To elucidate the functional consequences of HO-1 modulation on iron homeostasis and breast cancer cell behavior.

Main Methods:

• Analysis of HO-1 and iron-related protein expression in human breast cancer biopsies.
• In vivo studies using mice with altered HO-1 levels.
• In vitro experiments involving HO-1 activation in cancer cells.

Main Results:

• High HO-1 levels correlated with altered expression of iron transporters (DMT1, ZIP14) and iron storage proteins (hepcidin, L-ferritin) in human biopsies and mouse models.
• HO-1 activation in vitro increased iron accumulation (hemosiderin), reactive oxygen species (ROS), and lipid peroxidation.
• HO-1 activation decreased breast cancer cell growth rate, an effect reversible by reducing iron or ROS levels.

Conclusions:

• HO-1 plays a significant role in regulating iron homeostasis within the breast cancer microenvironment.
• Modulation of HO-1 leads to iron dysregulation, oxidative stress, and impaired cancer cell viability, thereby hindering breast cancer progression.